bioM?rieux S.A. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BMXXY Over the counter 3840 www.biomerieux.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for bioM?rieux S.A.

BioMerieux SA (BMXMF) Full Year 2025 Earnings Call Highlights: Strong Organic Growth and ... - Feb 27th, 2026 2:05 pm
Why The Narrative Around bioMérieux (ENXTPA:BIM) Is Shifting As Analysts Rebalance Risk And Growth - Feb 24th, 2026 8:10 am
bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality - Feb 18th, 2026 7:30 am
Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors - Jan 12th, 2026 6:00 am
Clinical Microbiology Market Set to Reach USD 7.4 Billion by 2032, Driven by Advancements in Diagnostics and Rising Infectious Disease Rates – SNS Insider - Oct 28th, 2025 7:15 am
bioMerieux Product Pipeline and Strategy Analysis Report, 2025 - Oct 21st, 2025 9:25 am
Should Altesa BioSciences’ Use of SPOTFIRE Shift bioMérieux’s (ENXTPA:BIM) Diagnostic Market Position? - Sep 17th, 2025 6:00 am
OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence - Aug 26th, 2025 12:00 pm
bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM - Aug 5th, 2025 12:44 pm
Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific - Jul 16th, 2025 2:07 am